ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FG02 | BioTech | Ramucirumab - 500mg/50ml | 8493/388 | 131515/1 | CYRAMZA | 500mg/50ml | 1 x 10ml | Injectable solution | Infusion | Droguerie de l'Union | Eli Lilly and Company Indianapolis | USA | L.L | 2.44 | E2 | Eli Lilly and Company Indianapolis | USA | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FG02 | BioTech | Ramucirumab - 500mg/50ml | 8493 | 131515/1 | CYRAMZA | 500mg/50ml | 1 x 10ml | Injectable solution | Infusion | Droguerie de l'Union | Eli Lilly and Company Indianapolis | USA | 218,656,548 L.L | 2.44 | E2 | Eli Lilly and Company Indianapolis | USA | 12/12/20 | 0 |